EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The importance of gestational age in first trimester, maternal urine MALDI-Tof MS screening tests for Down Syndrome

Ray K Iles, Nicolaides K, Pais RJ, Zmuidinaite R, Keshavarz S, Poon LCY, Butler SA

Annals of Proteomics and Bioinformatics · 2019

DOI: 10.29328/journal.apb.1001008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Proteomics and Bioinformatics, 2019. Verfasst von Ray K Iles und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The proposal that MALDI-ToF mass spectrometry could be used as a direct, rapid and affordable diagnostic tool in clinical laboratory medicine has moved from a theoretical possibility to a reality for Microbiology. Several studies have proposed the application of this technology in obstetric and gynaecological evaluation of patients. In particular, we have proposed that the adoption of MALDI-ToF mass spectrometry in examination of maternal pregnancy urine samples for the detection of Downs syndrome.

Methods

A retrospective collection of 20 Down Syndrome and 100 non-aneuploid pregnancy urines at 12 to 14 weeks gestation, collected in 2007-2008 from high risk pregnancy cohorts, were examined by MALDI-ToF mass spectrometry in the mass/charge range between 1000 and 100000 m/z. Normalisation of spectral data was defined using mass bins of 100 m/z expressed as a percentage of the total ion count of the mass spectra from 2000 to 11000 m/z. Of the ninety 100 m/z bins, forty-six were identified as m/z bins at which statistically significant differences in spectra occurred between Downs and control/non-aneuploid samples. Based on the differences and variance, for values at these bins, weighted scores of the probability of being Downs were assigned. Comparative algorithms consisting of various mass bins were tested for ability to distinguish Down syndrome from non-aneuploid pregnancy.

Results

Although various algorithms could distinguish Downs from non-aneuploid controls, it was found that gestational age was a confounding factor and that if separated into gestational age matched cohorts the ability to distinguish the groups improved dramatically e.g. whilst a 19 bins algorithm separated 100% of Downs from non-aneuploid pregnancies for a 9% false positive rate in the mixed gestational ages group; a two bin algorithm distinguished 100% of Downs for a 6% false positive rate for the 12 weeks gestational age pregnancies.

Conclusion

Normalised MALDI-ToF mass spectra, at 2000 to 11000 m/z, of maternal urine gives rise to gestational age specific screening tests algorithms for Downs’s syndrome.

Zitieren

APA

Iles, R. K., K, N., RJ, P., R, Z., S, K., LCY, P., & SA, B. (2019). The importance of gestational age in first trimester, maternal urine MALDI-Tof MS screening tests for Down Syndrome. Annals of Proteomics and Bioinformatics. https://doi.org/10.29328/journal.apb.1001008

Vancouver

Iles RK, K N, RJ P, R Z, S K, LCY P, et al. The importance of gestational age in first trimester, maternal urine MALDI-Tof MS screening tests for Down Syndrome. Annals of Proteomics and Bioinformatics. 2019. doi:10.29328/journal.apb.1001008

BibTeX
@article{Iles2019,
  author = {Iles, Ray K and K, Nicolaides and RJ, Pais and R, Zmuidinaite and S, Keshavarz and LCY, Poon and SA, Butler},
  title = {The importance of gestational age in first trimester, maternal urine MALDI-Tof MS screening tests for Down Syndrome},
  journal = {Annals of Proteomics and Bioinformatics},
  year = {2019},
  doi = {10.29328/journal.apb.1001008}
}
Kostenlos starten →